Prothena Corporation plc

PRTA ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $1.0M $51.1M $21.0K $2.4M $4.4M $2.8M $2.1M $970.0K
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development $8.8M $12.6M $14.6M $28.9M $40.5M $50.8M $50.2M $50.7M
SG&A Expense $10.9M $12.7M $12.6M $13.2M $15.9M $17.6M $16.8M $16.8M
Operating Income $-21.1M $30.0M $-24.2M $-40.2M $-84.6M $-65.6M $-64.9M $-66.5M
Operating Margin -2,089.2% 58.8% -115,252.4% -1,666.3% -1,914.4% -2,319.0% -3,056.9% -6,857.0%
Interest Expense — — — — — — — —
Pretax Income $-18.6M $32.7M $-21.6M $-36.9M $-81.0M $-61.4M $-59.5M $-59.8M
Income Tax Expense $2.0K $1.0K $10.0K $-371.0K $44.8M $-1.2M $-1.5M $-835.0K
Net Income $-18.6M $32.7M $-21.6M $-36.5M $-125.8M $-60.2M $-58.0M $-59.0M
Net Margin -1,839.9% 64.1% -102,804.8% -1,513.1% -2,845.4% -2,128.5% -2,729.9% -6,082.6%
EPS (Basic) $-0.36 $0.61 $-0.39 $-0.68 $-2.34 $-1.12 $-1.07 $-1.10
EPS (Diluted) $-0.36 $0.60 $-0.39 $-0.68 $-2.34 $-1.12 $-1.05 $-1.10
Shares Outstanding (Basic) 52.1M 53.7M 53.8M 53.8M 53.8M 53.8M 53.8M 53.8M
Shares Outstanding (Diluted) 52.1M 54.1M 53.8M 53.8M 53.8M 53.8M 53.8M 53.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 7 Older →